The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Self-citationBatchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Tofts, P. S., & Kermode, A. G. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910170208 · Cited by 1,456
Rougier, P., Adenis, A., Ducreux, M., de Forni, M., Bonneterre, J., Dembak, M., Clouet, P., Lebecq, A., Baille, P., Lefresne-Soulas, F., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00072-1 · Cited by 751
Morgan, B., Thomas, A. L., Drevs, J., Hennig, J., Buchert, M., Jivan, A., Horsfield, M. A., Mross, K., Ball, H. A., Lee, L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.092 · Cited by 652
Vascular Targeting Agents as Cancer Therapeutics
Thorpe, P. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0642-03 · Cited by 577
Spratlin, J. L., Cohen, R. B., Eadens, M., Gore, L., Camidge, D. R., Diab, S., Leong, S., O'Bryant, C., Chow, L. Q. M., Serkova, N. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7537 · Cited by 549
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Kloos, R. T., Ringel, M. D., Knopp, M. V., Hall, N. C., King, M., Stevens, R., Liang, J., Wakely, P. E., Vasko, V. V., Saji, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2717 · Cited by 541
Wedam, S. B., Low, J. A., Yang, S. X., Chow, C. K., Choyke, P., Danforth, D., Hewitt, S. M., Berman, A., Steinberg, S. M., Liewehr, D. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4645 · Cited by 518
Leach, M. O., Brindle, K. M., Evelhoch, J. L., Griffiths, J. R., Horsman, M. R., Jackson, A., Jayson, G. C., Judson, I. R., Knopp, M. V., Maxwell, R. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602550 · Cited by 513
Self-citationSiegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., Chen, H., Clark-Garvey, S., Weinberg, A., Mandeli, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9947 · Cited by 506
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
O'Connor, J. P. B., Jackson, A., Parker, G. J. M., & Jayson, G. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603515 · Cited by 484
Self-citationZhu, A. X., Sahani, D. V., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Catalano, O. A., Sindhwani, V., Blaszkowsky, L. S., Yoon, S. S., Lahdenranta, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9908 · Cited by 477
Phase I Trial of Pazopanib in Patients with Advanced Cancer
Hurwitz, H. I., Dowlati, A., Saini, S., Savage, S., Suttle, A. B., Gibson, D. M., Hodge, J. P., Merkle, E. M., & Pandite, L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2740 · Cited by 418
Dowlati, A., Robertson, K., Cooney, M. M., Petros, W. P., Stratford, M. R. L., Jesberger, J. A., Rafie, N., Overmoyer, B. A., Makkar, V., Stambler, B. S., et al. (2002) · PubMed · Cited by 403
Herbst, R. S., Ansari, R., Bustin, F., Flynn, P., Hart, L., Otterson, G. A., Vlahovic, G., Soh, C.-H., O'Connor, P., & Hainsworth, J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60545-x · Cited by 392
Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
Lam, E. T., Ringel, M. D., Kloos, R. T., Prior, T. W., Knopp, M. V., Liang, J., Sammet, S., Hall, N. C., Wakely, P. E., Vasko, V. V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0068 · Cited by 377
Gutin, P. H., Iwamoto, F. M., Beal, K., Mohile, N. A., Karimi, S., Hou, B. L., Lymberis, S., Yamada, Y., Chang, J., & Abrey, L. E. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.043 · Cited by 370
Galbraith, S. M., Lodge, M. A., Taylor, N. J., Rustin, G. J. S., Bentzen, S., Stirling, J. J., & Padhani, A. R. (2002) · NMR in Biomedicine · doi:10.1002/nbm.731 · Cited by 338
Translating cancer research into targeted therapeutics
de Bono, J. S., & Ashworth, A. (2010) · Nature · doi:10.1038/nature09339 · Cited by 335
Drevs, J., Siegert, P., Medinger, M., Mross, K., Strecker, R., Zirrgiebel, U., Harder, J., Blum, H., Robertson, J., Jürgensmeier, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2066 · Cited by 303
Jackson, A., O'Connor, J. P. B., Parker, G. J. M., & Jayson, G. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0238 · Cited by 299
Self-citationStevenson, J. P., Rosen, M., Sun, W., Gallagher, M., Haller, D. G., Vaughn, D., Giantonio, B., Zimmer, R., Petros, W. P., Stratford, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.986 · Cited by 291
Liu, G., Rugo, H. S., Wilding, G., McShane, T. M., Evelhoch, J. L., Ng, C., Jackson, E., Kelcz, F., Yeh, B. M., Lee, F. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.143 · Cited by 260
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Self-citationEder, J. P., Supko, J. G., Clark, J. W., Puchalski, T. A., Garcia-Carbonero, R., Ryan, D. P., Shulman, L. N., Proper, J., Kirvan, M., Rattner, B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.082 · Cited by 243
Lockhart, A. C., Rothenberg, M. L., Dupont, J., Cooper, W., Chevalier, P., Sternas, L., Buzenet, G., Koehler, E., Sosman, J. A., Schwartz, L. H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9237 · Cited by 232
Hahn, O. M., Yang, C., Medved, M., Karczmar, G., Kistner, E., Karrison, T., Manchen, E., Mitchell, M., Ratain, M. J., & Stadler, W. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5655 · Cited by 230
Thomas, A. L., Morgan, B., Horsfield, M. A., Higginson, A., Kay, A., Lee, L., Masson, E., Puccio-Pick, M., Laurent, D., & Steward, W. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.034 · Cited by 228
Iwamoto, F. M., Lamborn, K. R., Robins, H. I., Mehta, M. P., Chang, S. M., Butowski, N. A., DeAngelis, L. M., Abrey, L. E., Zhang, W.-T., Prados, M. D., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq025 · Cited by 223
Multiparametric Imaging of Tumor Response to Therapy
Padhani, A. R., & Miles, K. A. (2010) · Radiology · doi:10.1148/radiol.10091760 · Cited by 222
Miller, K. D., Trigo, J. M., Wheeler, C., Barge, A., Rowbottom, J., Sledge, G., & Baselga, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1923 · Cited by 198
Gururangan, S., Chi, S. N., Young Poussaint, T., Onar-Thomas, A., Gilbertson, R. J., Vajapeyam, S., Friedman, H. S., Packer, R. J., Rood, B. N., Boyett, J. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8789 · Cited by 194
Flaherty, K. T., A. Rosen, M., F. Heitjan, D., L. Gallagher, M., Schwartz, B., D. Schnall, M., & O'Dwyer, P. J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.4.5624 · Cited by 193
Measuring response in a post-RECIST world: from black and white to shades of grey
Michaelis, L. C., & Ratain, M. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1883 · Cited by 192
Rosen, L. S., Kurzrock, R., Mulay, M., Van Vugt, A., Purdom, M., Ng, C., Silverman, J., Koutsoukos, A., Sun, Y.-N., Bass, M. B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8170 · Cited by 188
Hecht, J. R., Trarbach, T., Hainsworth, J. D., Major, P., Jäger, E., Wolff, R. A., Lloyd-Salvant, K., Bodoky, G., Pendergrass, K., Berg, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.4496 · Cited by 178
Karrison, T. G., Maitland, M. L., Stadler, W. M., & Ratain, M. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm158 · Cited by 177
Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
Mross, K., Stefanic, M., Gmehling, D., Frost, A., Baas, F., Unger, C., Strecker, R., Henning, J., Gaschler-Markefski, B., Stopfer, P., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0694 · Cited by 171
Machiels, J.-P. H., Henry, S., Zanetta, S., Kaminsky, M.-C., Michoux, N., Rommel, D., Schmitz, S., Bompas, E., Dillies, A.-F., Faivre, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8584 · Cited by 171
Mross, K., Drevs, J., Müller, M., Medinger, M., Marmé, D., Hennig, J., Morgan, B., Lebwohl, D., Masson, E., Ho, Y.-Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.005 · Cited by 165
Koh, D.-M., Blackledge, M., Collins, D. J., Padhani, A. R., Wallace, T., Wilton, B., Taylor, N. J., Stirling, J. J., Sinha, R., Walicke, P., et al. (2009) · European Radiology · doi:10.1007/s00330-009-1469-4 · Cited by 163
O’Connor, J. P. B., Carano, R. A. D., Clamp, A. R., Ross, J., Ho, C., Jackson, A., Parker, G. J. M., Rose, C. J., Peale, F. V., Jr., Friesenhahn, M. J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0731 · Cited by 157
Self-citationGalbraith, S. M., Rustin, G. J. S., Lodge, M. A., Taylor, N. J., Stirling, J., Jameson, M. B., Thompson, P. I., Hough, D., Gumbrell, L. A., & Padhani, A. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.144 · Cited by 144
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma
Jackson, A., Jayson, G. C., Li, K., Zhu, X., Checkley, D., Tessier, J. J. L., & Waterton, J. C. (2003) · British Journal of Radiology · doi:10.1259/bjr/70653746 · Cited by 136
Self-citationde Lussanet, Q. G., Backes, W. H., Griffioen, A. W., Padhani, A. R., Baeten, C. I. M., van Baardwijk, A. A. W., Lambin, P., Beets, G. L., van Engelshoven, J. M. A., & Beets‐Tan, R. G. H. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.04.052 · Cited by 132
Posey, J. A., Ng, T. C., Yang, B., Khazaeli, M. B., Carpenter, M., Fox, F. E., Needle, M., Waksal, H. W., & LoBuglio, A. F. (2003) · PubMed · Cited by 119
Hsu, C., Shen, Y., Yu, C., Hsu, C., Hu, F., Hsu, C., Chen, B., Wei, S., Cheng, A., & Shih, T. T. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.032 · Cited by 119
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
Kreisl, T. N., Zhang, W., Odia, Y., Shih, J. H., Butman, J. A., Hammoud, D. A., IWAMOTO, F. M., Sul, J., & Fine, H. A. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor091 · Cited by 115
Conrad, C., Friedman, H. S., Reardon, D. A., Provenzale, J., Jackson, E., Serajuddin, H., Laurent, D., Chen, B., & Yung, W. K. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.1512 · Cited by 112
Mita, M. M., Spear, M. A., Yee, L., Mita, A. C., Heath, E. I., Papadopoulos, K. P., Federico, K. C., Reich, S. D., Romero, O., Malburg, L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1096 · Cited by 105
Akisik, M. F., Sandrasegaran, K., Bu, G., Lin, C., Hutchins, G. D., & Chiorean, E. G. (2010) · Radiology · doi:10.1148/radiol.10091733 · Cited by 103
Baar, J., Silverman, P., Lyons, J. A., Fu, P., Abdul‐Karim, F. W., Ziats, N. P., Wasman, J. K., Hartman, P. H., Jesberger, J. A., Dumadag, L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2917 · Cited by 103
Sledge, G. W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.016 · Cited by 94
McKeage, M. J., Fong, P. C. C., Jeffery, M., Baguley, B. C., Kestell, P., Ravic, M., & Jameson, M. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1939 · Cited by 91
Wong, C., Koh, T.-S., Soo, R. A., Hartono, S., Thng, C. H., McKeegan, E. M., Yong, W. P., Chen, C.-S., Lee, S. C., Wong, J. W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7125 · Cited by 83
Jonker, D. J., Rosen, L. S., Sawyer, M. B., de Braud, F., Wilding, G., Sweeney, C. J., Jayson, G. C., McArthur, G. A., Rustin, G. J. S., Goss, G. D., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq599 · Cited by 74
Self-citationTon, N. C., Parker, G. J. M., Jackson, A., Mullamitha, S., Buonaccorsi, G. A., Roberts, C., Watson, Y., Davies, K. E., Cheung, S., Hope, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1550 · Cited by 73
Self-citationDingemans, A. C., de Langen, A. J., van den Boogaart, V., Marcus, J. T., Backes, W. H., Scholtens, H., van Tinteren, H., Hoekstra, O. S., Pruim, J., Brans, B. T., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq391 · Cited by 72
LoRusso, P. M., Gadgeel, S. M., Wozniak, A., Barge, A., Jones, H., DelProposto, Z., DeLuca, P., Evelhoch, J. L., Boerner, S. A., & Wheeler, C. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9112-9 · Cited by 71
Roberts, C., Little, R. A., Watson, Y., Zhao, S., Buckley, D. L., & Parker, G. J. M. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22593 · Cited by 70
Self-citationKelly, R. J., Rajan, A., Force, J. M., López-Chávez, A., Keen, C., Cao, L., Yu, Y., Choyke, P. L., Türkbey, B., Raffeld, M. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2331 · Cited by 70
Zweifel, M., & Padhani, A. R. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1451-z · Cited by 69
Rischin, D., Bibby, D. C., Chong, G., Kremmidiotis, G., Leske, A. F., Matthews, C. A., Wong, S., Rosen, M. A., & Desai, J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0937 · Cited by 61
Gregorc, V., Citterio, G., Vitali, G., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.005 · Cited by 54
Ceelen, W. P., Smeets, P., Backes, W. H., Damme, N. V., Boterberg, T., Demetter, P., Bouckenooghe, I., Visschere, M. D., Peeters, M., & Pattyn, P. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.026 · Cited by 53
Mross, K. B., Fasol, U., Frost, A., Benkelmann, R., Kuhlmann, J. B., Büchert, M., Unger, C., Blum, H. E., Hennig, J., Milenkova, T., et al. (2009) · Vascular Cell · doi:10.1186/2040-2384-1-5 · Cited by 53
Overmoyer, B. A., Fu, P., Hoppel, C. L., Radivoyevitch, T., Shenk, R., Persons, M., Silverman, P., Robertson, K., Ziats, N. P., Wasman, J. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0688 · Cited by 50
van Laarhoven, H. W. M., Fiedler, W., Desar, I. M. E., van Asten, J. J. A., Marreaud, S. I., Lacombe, D., Govaerts, A.-S., Bogaerts, J., Lasch, P., Timmer-Bonte, J. N. H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1621 · Cited by 41
Barnthouse, L. W., Munns, W. R., & Sorensen, M. T. (2007) · CRC Press eBooks · doi:10.1201/9781420053333.ch11 · Cited by 40
Ricart, A. D., Ashton, E. A., Cooney, M. M., Sarantopoulos, J., Brell, J. M., Feldman, M., Ruby, K. E., Matsuda, K., Munsey, M. S., Medina, G. E., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1565-4 · Cited by 31
Kummar, S., Gutierrez, M. E., Chen, A. P., Turkbey, I. B., Allen, D. E., Horneffer, Y. R., Juwara, L., Cao, L., Yu, Y., Kim, Y. S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.016 · Cited by 23
Redalen, K. R., Seierstad, T., Kristian, A., Mikalsen, L. T. G., Mælandsmo, G. M., van der Kogel, A. J., Ree, A. H., & Olsen, D. R. (2010) · Neoplasia · doi:10.1593/neo.10484 · Cited by 13
Cited by
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Self-citationImaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
O'Connor, J. P. B., Rose, C. J., Waterton, J. C., Carano, R. A. D., Parker, G. J. M., & Jackson, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0990 · Cited by 677
Self-citationHeye, A. K., Culling, R. D., Valdés Hernández, M. D. C., Thrippleton, M. J., & Wardlaw, J. M. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.09.002 · Cited by 406
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 383
Markers of Response for the Antiangiogenic Agent Bevacizumab
Lambrechts, D., Lenz, H.-J., de Haas, S., Carmeliet, P., & Scherer, S. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2762 · Cited by 332
Metadata
- Authors
- O'Connor, J. P. B., Jackson, A., Parker, G. J. M., Roberts, C., & Jayson, G. C.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2012-02-14
- Volume
- 9
- Issue
- 3
- Pages
- 167-177
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2091320739
- Cited by
- 348
- References
- 74
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.